Lipocine, Inc. (LPCN)
1.615
+0.08
(+5.56%)
USD |
NASDAQ |
Nov 06, 10:25
Lipocine Gross Profit Margin (Quarterly) : 92.32% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 92.32% |
| March 31, 2026 | 87.60% |
| December 31, 2025 | 98.69% |
| September 30, 2025 | 87.70% |
| June 30, 2025 | 97.41% |
| March 31, 2025 | 83.39% |
| December 31, 2024 | 99.55% |
| September 30, 2024 | |
| June 30, 2024 | 90.51% |
| March 31, 2024 | 99.89% |
| December 31, 2023 | 85.45% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | 91.27% |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 99.48% |
| Date | Value |
|---|---|
| March 31, 2022 | |
| December 31, 2021 | 100.00% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | 0.00% |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 68.11% |
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.65% |
| Veru, Inc. | -- |
| Eli Lilly & Co. | 83.88% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -65.59% |
| Return on Assets | -58.76% |
| Return on Invested Capital | -65.59% |
| Profit Margin (Quarterly) | -1.38K% |
| Operating Margin (Quarterly) | -1.50K% |
| Return on Net Operating Assets | -11.37K% |